193528-31-3 Usage
Uses
Used in Pharmaceutical Applications:
(4R)-4-(2-Furanyl)-2-oxazolidinone is used as a building block for the synthesis of various bioactive molecules in the pharmaceutical industry. Its distinct structure and properties make it a valuable component in drug discovery and development, particularly in the field of medicinal chemistry.
Used in Antimicrobial and Antibacterial Applications:
(4R)-4-(2-Furanyl)-2-oxazolidinone is used as a molecule of interest in the search for new antibiotics and antimicrobial agents. Its potential antimicrobial and antibacterial properties have been investigated, making it a promising candidate for the development of novel treatments to combat drug-resistant infections.
Check Digit Verification of cas no
The CAS Registry Mumber 193528-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,5,2 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 193528-31:
(8*1)+(7*9)+(6*3)+(5*5)+(4*2)+(3*8)+(2*3)+(1*1)=153
153 % 10 = 3
So 193528-31-3 is a valid CAS Registry Number.
193528-31-3Relevant academic research and scientific papers
New synthetic strategy for chiral 2-oxazolidinones derivatives via rhodium-catalyzed asymmetric hydrogenation
Wang, Qingli,Tan, Xuefeng,Zhu, Ziyue,Dong, Xiu-Qin,Zhang, Xumu
, p. 658 - 662 (2016/01/26)
Asymmetric hydrogenation of 4-substituted cyclic enamido esters catalyzed by a rhodium-TangPhos complex provides an efficient method for the synthesis of chiral 4-substituted oxazolinones with excellent yields and good enantioselectivities. The products are valuable chiral building blocks and the applications as chiral auxiliaries and pharmaceuticals are well-known.
Kinetic resolution of 2-oxazolidinones via catalytic, enantioselective N-acylation
Birman, Vladimir B.,Jiang, Hui,Li, Ximin,Guo, Lei,Uffman, Eric W.
, p. 6536 - 6537 (2007/10/03)
Kinetic resolution of racemic 2-oxazolidinones via catalytic, enantioselective N-acylation has been achieved for the first time and with outstanding selectivities. Copyright
